Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
EGCG (epigallocatechin-3-gallate) is the predominant catechin polyphenol in green tea (Camellia sinensis) that exerts potent antioxidant and anticancer effects through proteasome inhibition and epigenetic modulation. It specifically blocks chymotrypsin-like β5 and PGPH-like β1 proteasome activities while upregulating protective enzymes via Nrf2-ARE pathways.
Reported Benefits (Provisional)
Origin & History
Epigallocatechin gallate (EGCG) is a potent catechin and polyphenol found abundantly in the leaves of Camellia sinensis, commonly known as green tea. While green tea is cultivated globally, its origins trace back to East Asia. EGCG is the most bioactive compound in green tea, widely studied for its significant antioxidant, anti-inflammatory, and metabolic benefits, making it a cornerstone of functional nutrition.
Research Narrative (Provisional)
Extensive research, including numerous in vitro, animal, and human clinical trials, supports EGCG's roles in antioxidant defense, cardiovascular health, and metabolic regulation. While promising, evidence for specific disease prevention, particularly cancer, often comes from epidemiological or preliminary studies, warranting further large-scale human trials.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Polyphenols: Epigallocatechin gallate (EGCG), the primary bioactive catechin. - Flavonoids: Other catechins like epicatechin (EC), epigallocatechin (EGC), and epicatechin gallate (ECG).
Reported Mechanism (Provisional)
EGCG activates Nrf2-ARE pathways to upregulate protective enzymes including SOD, GPx, CAT, GST, and GR while generating low-level ROS at physiological concentrations (1-10 μM) to trigger protective cellular signals. It specifically inhibits proteasome chymotrypsin-like β5 and PGPH-like β1 activities, leading to accumulation of p27 and IκB-α proteins and G1 cell cycle arrest. EGCG also functions as an epigenetic modulator by inhibiting DNMT and HAT enzymes, reactivating tumor suppressor genes including GSTP1, p16, p21WAF1, and Bax.
Clinical Narrative (Provisional)
Research on EGCG consists primarily of extensive in vitro studies using cancer cell lines (HepG2, JB6, A549, prostate cancer cells) and animal models rather than large-scale human clinical trials. Preclinical studies demonstrate quantifiable effects including 110.42% increased EGCG extraction efficiency and significant antioxidant activity enhancement (p<0.05) using optimized extraction methods. While epidemiological studies suggest cardiovascular and metabolic benefits, specific clinical trial data with participant numbers, dosages, and statistical outcomes are limited. The evidence for cancer prevention and treatment remains primarily observational and preclinical, warranting further large-scale human randomized controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.